Barbara A Haber - Biesecker Pediatric Liver Center, Children’s Hospital of Philadelphia

基本信息

Career Trajectory

Bio

Barbara A Haber currently works at Merck Research Laboratories in late stage clinical development. Previously she was employed by the Division of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia. Barbara does research in Hepatology and Pediatrics. Her most recent publication is 'Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: final results of the C-ISLE study.'

Research Interests

Papers共 176 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients

Andreas H. Groll,Johannes H. Schulte,Ali Buelent Antmen,Christopher J. Fraser,Valerie L. Teal,Barbara Haber,Luzelena Caro,Jacqueline B. McCrea,Craig Fancourt, Mayankbhai Patel,Karsten Menzel,Cyrus Badshah

PEDIATRIC INFECTIOUS DISEASE JOURNALno. 3 (2024): 203-208

Cited1Views0WOSBibtex

Cytomegalovirus Antiviral Resistance among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir Vs Valganciclovir Prophylaxis

Julie M. Strizki,Tracy L. Diamond,Valerie L. Teal,Christopher L. Gilbert, Weiwen Wang,Nicole Stauffer,Barbara A. Haber

The Journal of infectious diseasesno. 6 (2024): e1287-e1298

Cited0Views0WOSBibtex

Letermovir Safety and Efficacy for Cytomegalovirus Prophylaxis in Adult Japanese Kidney Transplant Recipients: a Multicenter, Open-Label, Noncomparative Phase 3 Study

Hideki Ishida,Norihiko Goto,Ryoichi Imamura,Hajime Sasaki,Kohei Unagami,Kenta Futamura,Yoshihiko Murata, Nobuyuki Oshima, Toshiko Eto,Barbara Haber

CLINICAL AND EXPERIMENTAL NEPHROLOGYno. 8 (2024): 822-831

Cited0Views0WOSBibtex

Letermovir Vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial

Ajit P. Limaye,Klemens Budde,Atul Humar,Flavio Vincenti,Dirk R. J. Kuypers,Robert P. Carroll,Nicole Stauffer,Yoshihiko Murata,Julie M. Strizki,Valerie L. Teal,Christopher L. Gilbert,Barbara A. Haber

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONno. 1 (2023): 33-42

Cited35Views0WOSBibtex

Effectiveness of Elbasvir/grazoprevir Plus Ribavirin for Hepatitis C Virus Genotype 1a Infection and Baseline NS5A Resistance

Deanna D. Hill,Jennifer R. Kramer, Kassie R. Chaffin,T. Christopher Mast,Michael N. Robertson,Fasiha Kanwal,Barbara A. Haber

Annals of Hepatology（2023）

Cited1Views0WOSBibtex

Olav Dalgard,Alain H. Litwin,Oren Shibolet,Jason Grebely,Ronald Nahass,Frederick L. Altice,Brian Conway,Edward J. Gane,Anne F. Luetkemeyer,Cheng-Yuan Peng,David Iser,Isaias Noel Gendrano,Michelle M. Kelly,Barbara A. Haber,Heather Platt,Amy Puenpatom

JOURNAL OF ADDICTIVE DISEASES（2023）

Cited2Views0WOSBibtex

A phase 3 randomized, placebo-controlled trial evaluating safety and efficacy of letermovir prophylaxis extended from 100 to 200 days post-transplant in cytomegalovirus-seropositive allogeneic hsct recipients

Domenico Russo,Sanjeet S. Dadwal,Matthias Stelljes, Michael Schmit,Sylvain Pilorge,Valerie L. Teal,Barbara Haber, Charlene Bopp,Cyrus Badshah

BONE MARROW TRANSPLANTATIONno. SUPP1 (2023): 86-87

Cited0Views0Bibtex

Efficacy and Safety of Extended Duration Letermovir Prophylaxis in Recipients of Haematopoietic Stem-Cell Transplantation at Risk of Cytomegalovirus Infection: a Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Domenico Russo,Michael Schmitt,Sylvain Pilorge,Matthias Stelljes,Toshiro Kawakita,Valerie L. Teal,Barbara Haber, Charlene Bopp,Sanjeet S. Dadwal,Cyrus Badshah

The Lancet Haematology（2023）

Cited8Views0WOSBibtex

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Letermovir (LET) Prophylaxis when Extended from 100 to 200 Days Post-Transplant in Cytomegalovirus (Cmv)-Seropositive Recipients (R+) of an Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Sanjeet Singh Dadwal,Domenico Russo,Matthias Stelljes,Michael Schmitt,Sylvain Pilorge,Valerie L. Teal,Barbara A. Haber, Charlene Bopp,Cyrus Badshah

Transplantation and Cellular Therapyno. 2 (2023): S64

Cited5Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn